AstriVax is pleased to welcome Dr. Gregory Fanning as its Chief Business Officer. He will lead our business development, asset partnering, new program evaluation, public-private partnerships, non-dilutive funding, and pipeline strategy. Greg will play a key role in our lead therapeutic program on chronic Hepatitis B.